3Q9O
Full-length Cholix toxin from Vibrio cholerae in complex with NAD
Summary for 3Q9O
| Entry DOI | 10.2210/pdb3q9o/pdb |
| Related | 2Q5T 2Q6M 3ESS |
| Descriptor | exotoxin A, NICOTINAMIDE-ADENINE-DINUCLEOTIDE, GLYCEROL, ... (4 entities in total) |
| Functional Keywords | receptor binding domain, beta barrel, translocation, six alpha-helix bundle, alpha-beta complex, adp-ribosylating factor, diphthamide on eukaryotic elongation factor 2, transferase |
| Biological source | Vibrio cholerae |
| Total number of polymer chains | 1 |
| Total formula weight | 72812.69 |
| Authors | Merrill, A.R.,Jorgensen, R.,Fieldhouse, R.J. (deposition date: 2011-01-09, release date: 2012-01-04, Last modification date: 2024-10-30) |
| Primary citation | Fieldhouse, R.J.,Jorgensen, R.,Lugo, M.R.,Merrill, A.R. The 1.8 a cholix toxin crystal structure in complex with NAD+ and evidence for a new kinetic model. J.Biol.Chem., 287:21176-21188, 2012 Cited by PubMed Abstract: Certain Vibrio cholerae strains produce cholix, a potent protein toxin that has diphthamide-specific ADP-ribosyltransferase activity against eukaryotic elongation factor 2. Here we present a 1.8 Å crystal structure of cholix in complex with its natural substrate, nicotinamide adenine dinucleotide (NAD(+)). We also substituted hallmark catalytic residues by site-directed mutagenesis and analyzed both NAD(+) binding and ADP-ribosyltransferase activity using a fluorescence-based assay. These data are the basis for a new kinetic model of cholix toxin activity. Further, the new structural data serve as a reference for continuing inhibitor development for this toxin class. PubMed: 22535961DOI: 10.1074/jbc.M111.337311 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (1.793 Å) |
Structure validation
Download full validation report






